TG Therapeutics (TGTX) Shares Move Up from Lows Amid Amended GENUINE Phase 3 Protocol

October 13, 2016 7:24 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

TG Therapeutics (Nasdaq: TGTX) shares are seeing a slight rebound Thursday morning after the company announced an amended protocol for its GENUINE Phase 3 trial. The stock is down around 4 percent, but was 22 percent lower Wednesday night.

For more on the updated protocol, click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Add Your Comment